Interleukin-1 Receptor Antagonist [EPC]

Interleukin-1 Receptor Antagonist [EPC] was reported 16900 times

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 302 0.8988
1 INFILTRATION ANAESTHESIA 22 0.6875
2 ACTINOMYCOTIC SEPSIS 17 0.6800
3 HUMAN ANTI-HUMAN ANTIBODY TEST 16 0.5926
4 BODY HEIGHT BELOW NORMAL 312 0.4852
5 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
6 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 11 0.3548
7 ALPHA TUMOUR NECROSIS FACTOR INCREASED 30 0.3226
8 SERUM AMYLOID A PROTEIN INCREASED 46 0.2968
9 AUTOINFLAMMATORY DISEASE 58 0.2736
10 ANKLE ARTHROPLASTY 96 0.2645
11 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 15 0.2500
12 SHORT STATURE 59 0.2252
13 INTESTINAL SEPSIS 51 0.1947
14 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 423 0.1834
15 JOINT DESTRUCTION 256 0.1645
16 PROPIONIBACTERIUM INFECTION 17 0.1589
17 SKIN GRAFT INFECTION 10 0.1562
18 JUVENILE IDIOPATHIC ARTHRITIS 372 0.1520
19 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 26 0.1494
20 ANTIBODY TEST POSITIVE 235 0.1415
21 INTERLEUKIN LEVEL INCREASED 76 0.1377
22 HAIR FOLLICLE TUMOUR BENIGN 15 0.1351
23 HEPATOSPLENIC T-CELL LYMPHOMA 48 0.1294
24 BONE DENSITY INCREASED 50 0.1253
25 HERPES ZOSTER INFECTION NEUROLOGICAL 19 0.1195
26 VEXAS SYNDROME 11 0.1146
27 AUTOIMMUNE PANCYTOPENIA 10 0.1099
28 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 21 0.1071
29 HYPERFERRITINAEMIA 46 0.1067
30 BODY TINEA 58 0.1036
31 TESTICULAR SEMINOMA (PURE) 12 0.1008
32 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 725 0.0965
33 SOFT TISSUE DISORDER 106 0.0956
34 PNEUMONIA LIPOID 13 0.0949
35 POLYARTHRITIS 498 0.0944
36 PARVOVIRUS INFECTION 38 0.0941
37 APPARENT DEATH 323 0.0896
38 DRUG SPECIFIC ANTIBODY 120 0.0876
39 GROWTH FAILURE 30 0.0872
40 CLUBBING 35 0.0858
41 DIAPHRAGM MUSCLE WEAKNESS 13 0.0823
42 FAMILIAL MEDITERRANEAN FEVER 16 0.0816
43 EPIDURAL LIPOMATOSIS 26 0.0756
44 POLYARTERITIS NODOSA 44 0.0753
45 BREAST ULCERATION 10 0.0719
46 HYPERTENSIVE CARDIOMYOPATHY 19 0.0683
47 ORAL MUCOSAL EXFOLIATION 103 0.0680
48 RHEUMATOID FACTOR POSITIVE 391 0.0676
49 SPINAL CORD INJURY CERVICAL 17 0.0675
50 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 10 0.0662
51 IMMOBILISATION SYNDROME 14 0.0657
52 VASCULITIC RASH 48 0.0622
53 C-REACTIVE PROTEIN ABNORMAL 398 0.0620
54 JUVENILE ARTHRITIS 20 0.0610
55 SOFT TISSUE SWELLING 34 0.0599
56 RED BLOOD CELL SEDIMENTATION RATE INCREASED 646 0.0583
57 COMPLICATIONS OF BONE MARROW TRANSPLANT 21 0.0582
58 ARTHRODESIS 57 0.0560
59 DISSEMINATED MUCORMYCOSIS 22 0.0558
60 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0543
61 SPLENIC ABSCESS 22 0.0541
62 JOINT ARTHROPLASTY 96 0.0536
63 ADRENAL SUPPRESSION 43 0.0510
64 COLD URTICARIA 11 0.0500
65 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 11 0.0498
66 ALVEOLAR PROTEINOSIS 28 0.0473
67 STEROID DEPENDENCE 41 0.0467
68 SYNOVITIS 804 0.0445
69 WHEELCHAIR USER 195 0.0438
70 ADRENAL INSUFFICIENCY 529 0.0435
71 CYTOMEGALOVIRUS HEPATITIS 15 0.0424
72 EPSTEIN-BARR VIRAEMIA 44 0.0397
73 SMEAR CERVIX ABNORMAL 56 0.0394
74 BLOOD LACTATE DEHYDROGENASE DECREASED 13 0.0390
75 CLEAR CELL RENAL CELL CARCINOMA 27 0.0388
76 CONGENITAL APLASIA 12 0.0386
77 ANKLE OPERATION 56 0.0379
78 HISTIOCYTOSIS HAEMATOPHAGIC 110 0.0370
79 CELLULITIS STAPHYLOCOCCAL 24 0.0369
80 DRUG TOLERANCE 183 0.0361
81 PNEUMONIA VIRAL 109 0.0342
82 POST PROCEDURAL CONTUSION 11 0.0335
83 FINE MOTOR SKILL DYSFUNCTION 97 0.0335
84 INHIBITORY DRUG INTERACTION 52 0.0328
85 CUTANEOUS VASCULITIS 118 0.0323
86 FOCAL NODULAR HYPERPLASIA 16 0.0308
87 SERUM FERRITIN INCREASED 160 0.0303
88 OBESITY 479 0.0300
89 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 213 0.0297
90 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 170 0.0287
91 ADENOVIRUS INFECTION 83 0.0286
92 CONTRAINDICATED PRODUCT ADMINISTERED 848 0.0280
93 SYSTEMIC CANDIDA 68 0.0271
94 ACNE CYSTIC 80 0.0265
95 CHONDROCALCINOSIS 17 0.0260
96 INFECTION SUSCEPTIBILITY INCREASED 57 0.0260
97 LARYNGEAL STENOSIS 15 0.0260
98 VARICELLA ZOSTER VIRUS INFECTION 50 0.0241
99 POLYCHONDRITIS 10 0.0237
100 TERMINAL STATE 154 0.0230
101 PNEUMOCYSTIS JIROVECII INFECTION 27 0.0226
102 HYPOFIBRINOGENAEMIA 22 0.0222
103 CUSHINGOID 69 0.0215
104 INJECTION SITE HYPERSENSITIVITY 66 0.0211
105 DEFORMITY 196 0.0209
106 SPINAL STENOSIS 85 0.0206
107 SPONDYLOARTHROPATHY 12 0.0200
108 PULMONARY THROMBOSIS 215 0.0197
109 MENINGITIS LISTERIA 10 0.0196
110 OBSTRUCTIVE SLEEP APNOEA SYNDROME 28 0.0192
111 SHOULDER ARTHROPLASTY 50 0.0185
112 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 39 0.0183
113 FOOT OPERATION 89 0.0180
114 MYOPERICARDITIS 14 0.0179
115 C-REACTIVE PROTEIN INCREASED 649 0.0178
116 HYPERPLASIA 16 0.0178
117 MULTIPLE-DRUG RESISTANCE 54 0.0174
118 VIRAEMIA 24 0.0173
119 IMMUNODEFICIENCY 257 0.0172
120 ANAL STENOSIS 9 0.0169
121 SERUM FERRITIN DECREASED 29 0.0168
122 MENINGITIS VIRAL 23 0.0168
123 HAND DEFORMITY 216 0.0165
124 FOOT DEFORMITY 182 0.0164
125 INFLAMMATORY MARKER INCREASED 81 0.0163
126 WRIST DEFORMITY 10 0.0163
127 NODULE 210 0.0161
128 SENSITIVITY TO WEATHER CHANGE 84 0.0159
129 GRAFT VERSUS HOST DISEASE IN SKIN 35 0.0159
130 AMYLOIDOSIS 27 0.0156
131 CYTOMEGALOVIRUS INFECTION REACTIVATION 68 0.0154
132 THERAPEUTIC PRODUCT EFFECT DECREASED 682 0.0152
133 JOINT EFFUSION 104 0.0151
134 DIVERTICULITIS 414 0.0149
135 HEPATOSPLENOMEGALY 38 0.0148
136 CHRONIC SPONTANEOUS URTICARIA 17 0.0147
137 GRANULOMA SKIN 12 0.0146
138 CYTOKINE STORM 10 0.0146
139 OBLITERATIVE BRONCHIOLITIS 19 0.0145
140 ANTINUCLEAR ANTIBODY POSITIVE 47 0.0145
141 BRADYCARDIA FOETAL 12 0.0144
142 SEPTIC SHOCK 618 0.0142
143 GLUCOSE TOLERANCE IMPAIRED 83 0.0140
144 DRUG SPECIFIC ANTIBODY PRESENT 91 0.0140
145 RHEUMATOID ARTHRITIS 1556 0.0137
146 INJECTION SITE URTICARIA 335 0.0136
147 GROWTH RETARDATION 40 0.0136
148 LOCAL REACTION 10 0.0135
149 SERRATIA INFECTION 10 0.0134
150 PARVOVIRUS B19 INFECTION 12 0.0134
151 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 33 0.0133
152 GASTROENTERITIS VIRAL 238 0.0132
153 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
154 ENCEPHALITIS VIRAL 16 0.0131
155 RENAL MASS 27 0.0131
156 ARTHROPATHY 728 0.0131
157 CENTRAL NERVOUS SYSTEM LYMPHOMA 18 0.0131
158 TRANSPLANT FAILURE 31 0.0126
159 BONE DENSITY DECREASED 387 0.0123
160 SERONEGATIVE ARTHRITIS 14 0.0122
161 HUMAN HERPESVIRUS 6 INFECTION 23 0.0122
162 DRUG INTOLERANCE 1168 0.0121
163 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 46 0.0120
164 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 11 0.0119
165 SUPERFICIAL VEIN THROMBOSIS 10 0.0119
166 ENDODONTIC PROCEDURE 30 0.0118
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 566 0.0118
168 CYTOMEGALOVIRUS VIRAEMIA 52 0.0117
169 CYTOKINE RELEASE SYNDROME 231 0.0115
170 SKIN STRIAE 17 0.0114
171 PULMONARY FIBROSIS 218 0.0114
172 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 16 0.0113
173 VARICELLA 27 0.0113
174 MUSCULOSKELETAL DISORDER 211 0.0111
175 INJECTION SITE RASH 340 0.0111
176 BACTERIAL SEPSIS 36 0.0110
177 DEEP VEIN THROMBOSIS POSTOPERATIVE 22 0.0110
178 DISLOCATION OF VERTEBRA 25 0.0110
179 NORMOCYTIC ANAEMIA 16 0.0109
180 C-REACTIVE PROTEIN 10 0.0108
181 CYTOPENIA 130 0.0106
182 FIBROMYALGIA 258 0.0106
183 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 54 0.0106
184 SECONDARY ADRENOCORTICAL INSUFFICIENCY 16 0.0106
185 HYPOCALCAEMIA 200 0.0106
186 INFECTION REACTIVATION 12 0.0105
187 PSEUDOMONAL SEPSIS 18 0.0103
188 OPPORTUNISTIC INFECTION 19 0.0103
189 INJECTION SITE INFLAMMATION 51 0.0102
190 NEUROENDOCRINE CARCINOMA OF THE SKIN 10 0.0102
191 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 28 0.0101
192 EPSTEIN-BARR VIRUS INFECTION 62 0.0099
193 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 23 0.0099
194 JOINT SWELLING 1192 0.0099
195 MENINGITIS CRYPTOCOCCAL 17 0.0097
196 PEMPHIGUS 121 0.0097
197 THERAPY NON-RESPONDER 434 0.0096
198 BLOOD FIBRINOGEN DECREASED 11 0.0096
199 DEMYELINATION 39 0.0095
200 PAROTITIS 11 0.0095
201 LIVER FUNCTION TEST ABNORMAL 275 0.0094
202 ENTEROCOCCAL BACTERAEMIA 10 0.0094
203 RHEUMATOID NODULE 26 0.0094
204 RHEUMATIC FEVER 42 0.0094
205 MOBILITY DECREASED 670 0.0093
206 DRUG TOLERANCE DECREASED 26 0.0092
207 PERICARDITIS 154 0.0092
208 HERPES ZOSTER 526 0.0091
209 FUNGAEMIA 14 0.0089
210 ARTHRITIS 699 0.0089
211 LUPUS VULGARIS 11 0.0087
212 SECRETION DISCHARGE 107 0.0085
213 TREATMENT FAILURE 693 0.0084
214 PANNICULITIS 20 0.0083
215 FINGER DEFORMITY 40 0.0082
216 INJECTION SITE PRURITUS 553 0.0082
217 BLOOD PARATHYROID HORMONE DECREASED 12 0.0081
218 MUCORMYCOSIS 21 0.0081
219 INJECTION SITE REACTION 555 0.0081
220 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 205 0.0080
221 ILL-DEFINED DISORDER 475 0.0078
222 IMPAIRED QUALITY OF LIFE 112 0.0078
223 PYODERMA GANGRENOSUM 28 0.0078
224 ASPERGILLUS INFECTION 51 0.0078
225 GESTATIONAL HYPERTENSION 10 0.0077
226 HEPATITIS 198 0.0077
227 ENTEROBACTER INFECTION 13 0.0077
228 INJECTION SITE SCAR 22 0.0077
229 LIVER ABSCESS 25 0.0077
230 BLOOD PRESSURE SYSTOLIC ABNORMAL 19 0.0077
231 QUALITY OF LIFE DECREASED 103 0.0077
232 ORAL FUNGAL INFECTION 21 0.0077
233 HYPERTRANSAMINASAEMIA 53 0.0076
234 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 10 0.0076
235 STENT PLACEMENT 61 0.0076
236 KNEE ARTHROPLASTY 159 0.0075
237 BRONCHIAL HYPERREACTIVITY 9 0.0075
238 IMMUNE THROMBOCYTOPENIA 34 0.0074
239 HEPATOTOXICITY 163 0.0073
240 DIFFUSE LARGE B-CELL LYMPHOMA 56 0.0073
241 VITILIGO 17 0.0072
242 PNEUMONIA PSEUDOMONAL 11 0.0072
243 MULTIPLE ORGAN DYSFUNCTION SYNDROME 201 0.0071
244 PHOTOSENSITIVITY REACTION 117 0.0071
245 TENDERNESS 73 0.0070
246 BRONCHOPULMONARY ASPERGILLOSIS 54 0.0070
247 RETINITIS 12 0.0069
248 SACROILIITIS 13 0.0069
249 RESPIRATORY ACIDOSIS 27 0.0069
250 EXFOLIATIVE RASH 18 0.0068
251 BK VIRUS INFECTION 23 0.0068
252 INTERSTITIAL LUNG DISEASE 328 0.0068
253 FACET JOINT SYNDROME 22 0.0068
254 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 14 0.0068
255 PURPURA 59 0.0067
256 EPICONDYLITIS 10 0.0066
257 SWOLLEN JOINT COUNT INCREASED 21 0.0066
258 ERYSIPELAS 33 0.0066
259 LUNG OPACITY 17 0.0064
260 PULMONARY FUNCTION TEST ABNORMAL 10 0.0064
261 INFECTION 921 0.0064
262 LIVER FUNCTION TEST INCREASED 136 0.0063
263 EXTREMITY NECROSIS 11 0.0063
264 STREPTOCOCCAL INFECTION 35 0.0063
265 SCLERITIS 10 0.0062
266 BONE EROSION 22 0.0062
267 HISTOPLASMOSIS 11 0.0062
268 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 340 0.0062
269 INJECTION SITE WARMTH 127 0.0062
270 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 436 0.0061
271 VASOPLEGIA SYNDROME 10 0.0061
272 AUTOIMMUNE THYROIDITIS 23 0.0061
273 INJECTION SITE DISCOLOURATION 76 0.0061
274 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 58 0.0061
275 DRUG USE DISORDER 51 0.0061
276 SYNOVIAL CYST 28 0.0061
277 OFF LABEL USE 5297 0.0060
278 THROMBOCYTOSIS 22 0.0060
279 SALMONELLOSIS 10 0.0059
280 INJECTION SITE ERYTHEMA 732 0.0059
281 ESCHERICHIA SEPSIS 17 0.0059
282 TYPE IV HYPERSENSITIVITY REACTION 16 0.0058
283 CHOLESTATIC LIVER INJURY 13 0.0058
284 INJECTION SITE OEDEMA 10 0.0058
285 STAPHYLOCOCCAL BACTERAEMIA 25 0.0057
286 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
287 OSTEOPOROTIC FRACTURE 11 0.0057
288 CONDITION AGGRAVATED 1743 0.0057
289 DEEP VEIN THROMBOSIS 371 0.0057
290 FUNGAL SKIN INFECTION 23 0.0057
291 PNEUMONIA CYTOMEGALOVIRAL 11 0.0057
292 OSTEOMYELITIS 102 0.0056
293 BACTERAEMIA 66 0.0056
294 DISSEMINATED TUBERCULOSIS 14 0.0055
295 HYPOKALAEMIA 251 0.0054
296 INTENTIONAL PRODUCT USE ISSUE 474 0.0054
297 PERIPHERAL VENOUS DISEASE 22 0.0054
298 LIMB DISCOMFORT 164 0.0053
299 SPLENOMEGALY 62 0.0053
300 VENOOCCLUSIVE DISEASE 13 0.0052
301 INFLAMMATION 268 0.0052
302 ESCHERICHIA BACTERAEMIA 12 0.0051
303 INJECTION SITE INDURATION 66 0.0051
304 SPINAL COLUMN STENOSIS 24 0.0051
305 PRESCRIBED UNDERDOSE 101 0.0051
306 SWELLING 469 0.0050
307 VENTRICULAR DYSFUNCTION 13 0.0050
308 ONYCHOMADESIS 21 0.0050
309 GLOSSODYNIA 112 0.0050
310 ARTHRITIS INFECTIVE 23 0.0050
311 EMBOLISM 41 0.0049
312 ORAL HERPES 95 0.0049
313 AUTOIMMUNE DISORDER 47 0.0048
314 INJECTION SITE IRRITATION 61 0.0048
315 FIBRIN D DIMER INCREASED 17 0.0048
316 HYPOGAMMAGLOBULINAEMIA 31 0.0047
317 CYSTITIS HAEMORRHAGIC 19 0.0047
318 INFUSION SITE REACTION 14 0.0047
319 HYPERLIPIDAEMIA 56 0.0047
320 VENOOCCLUSIVE LIVER DISEASE 23 0.0047
321 LOCALISED INFECTION 112 0.0046
322 PLEURAL EFFUSION 280 0.0046
323 INJECTION SITE SWELLING 352 0.0046
324 JOINT INJURY 98 0.0046
325 PULMONARY EMBOLISM 435 0.0046
326 ENCEPHALITIS 31 0.0045
327 HEPATIC CYTOLYSIS 57 0.0045
328 BLOOD CHOLESTEROL INCREASED 208 0.0045
329 INJECTION SITE VESICLES 27 0.0045
330 IMPAIRED HEALING 145 0.0044
331 PNEUMOCYSTIS JIROVECII PNEUMONIA 44 0.0044
332 PUSTULAR PSORIASIS 15 0.0044
333 LOSS OF CONSCIOUSNESS 559 0.0044
334 CERVICAL VERTEBRAL FRACTURE 15 0.0043
335 ENTEROCOCCAL INFECTION 21 0.0043
336 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
337 BLOOD PRESSURE DIASTOLIC ABNORMAL 11 0.0043
338 LEUKOPENIA 216 0.0043
339 SYSTEMIC LUPUS ERYTHEMATOSUS 153 0.0043
340 HERPES SIMPLEX 28 0.0043
341 DUODENAL ULCER PERFORATION 32 0.0043
342 ACUTE RESPIRATORY DISTRESS SYNDROME 76 0.0043
343 HIDRADENITIS 39 0.0043
344 STAPHYLOCOCCAL SEPSIS 21 0.0042
345 NORMAL NEWBORN 23 0.0042
346 PNEUMATOSIS INTESTINALIS 12 0.0042
347 IMMUNOSUPPRESSION 37 0.0042
348 SEPSIS 466 0.0042
349 MUSCULOSKELETAL PAIN 217 0.0041
350 HYPERURICAEMIA 17 0.0041
351 VIRAL INFECTION 137 0.0041
352 WOUND INFECTION 45 0.0041
353 PSORIASIS 535 0.0041
354 REBOUND EFFECT 46 0.0041
355 PNEUMONIA FUNGAL 16 0.0041
356 LIVER INJURY 99 0.0040
357 CARDIAC DYSFUNCTION 15 0.0040
358 INJECTION SITE BRUISING 321 0.0040
359 STEM CELL TRANSPLANT 10 0.0040
360 SUSPECTED OFF LABEL USE 18 0.0040
361 CANDIDA INFECTION 67 0.0040
362 KLEBSIELLA INFECTION 20 0.0040
363 POOR QUALITY SLEEP 85 0.0039
364 HAEMODYNAMIC INSTABILITY 30 0.0039
365 GUILLAIN-BARRE SYNDROME 19 0.0039
366 IMMUNE SYSTEM DISORDER 51 0.0039
367 SPONDYLITIS 14 0.0038
368 GASTROINTESTINAL PERFORATION 16 0.0038
369 SYMPTOM RECURRENCE 23 0.0038
370 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 19 0.0038
371 PERICARDIAL EFFUSION 88 0.0038
372 CARDIAC TAMPONADE 18 0.0038
373 INJECTION SITE MASS 140 0.0038
374 CORONAVIRUS INFECTION 25 0.0038
375 ARTHROPOD BITE 28 0.0038
376 PSEUDOMONAS INFECTION 32 0.0037
377 MYCOBACTERIUM AVIUM COMPLEX INFECTION 10 0.0037
378 INTENTIONAL PRODUCT MISUSE 326 0.0037
379 MOUTH ULCERATION 78 0.0037
380 HYPERCAPNIA 11 0.0036
381 OSTEOARTHRITIS 154 0.0036
382 OTITIS MEDIA 12 0.0036
383 STOMATITIS 219 0.0036
384 RENAL FAILURE 477 0.0036
385 THROMBOTIC MICROANGIOPATHY 35 0.0036
386 MYOPATHY 31 0.0036
387 SKIN DISORDER 119 0.0036
388 BRAIN DEATH 11 0.0036
389 CELLULITIS 179 0.0035
390 BURSITIS 43 0.0035
391 LYMPHADENOPATHY 125 0.0035
392 VASCULITIS 41 0.0035
393 BACK DISORDER 57 0.0035
394 PYREXIA 1189 0.0034
395 IMMOBILE 15 0.0034
396 INJECTION SITE PAIN 1047 0.0034
397 HEPATIC STEATOSIS 63 0.0034
398 THORACIC VERTEBRAL FRACTURE 10 0.0034
399 IMPAIRED WORK ABILITY 72 0.0034
400 NECK PAIN 188 0.0034
401 INJECTION SITE INFECTION 11 0.0033
402 BREAST SWELLING 9 0.0033
403 LIVE BIRTH 28 0.0033
404 MIXED LIVER INJURY 10 0.0033
405 COVID-19 583 0.0033
406 DRUG INEFFECTIVE 4355 0.0033
407 OLIGOHYDRAMNIOS 11 0.0033
408 ESCHERICHIA URINARY TRACT INFECTION 14 0.0033
409 ENTERITIS 21 0.0033
410 OESOPHAGEAL CANDIDIASIS 13 0.0033
411 TONSILLITIS 17 0.0033
412 HYPERTRIGLYCERIDAEMIA 19 0.0032
413 LUNG DISORDER 159 0.0032
414 IMPAIRED GASTRIC EMPTYING 44 0.0032
415 FEAR OF INJECTION 23 0.0032
416 THERAPY PARTIAL RESPONDER 50 0.0032
417 PRESCRIBED OVERDOSE 62 0.0032
418 TOOTHACHE 58 0.0032
419 TIBIA FRACTURE 15 0.0032
420 PRODUCT DOSE OMISSION ISSUE 940 0.0032
421 ONYCHOMYCOSIS 14 0.0032
422 BLEPHAROSPASM 20 0.0032
423 ARTHRITIS BACTERIAL 13 0.0032
424 ADVERSE REACTION 42 0.0032
425 THROMBOSIS 254 0.0032
426 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
427 ULCER 50 0.0031
428 SCIATICA 50 0.0031
429 CYTOMEGALOVIRUS INFECTION 52 0.0031
430 DISSEMINATED INTRAVASCULAR COAGULATION 44 0.0031
431 EMBOLIC STROKE 11 0.0031
432 MENINGITIS ASEPTIC 14 0.0031
433 MUSCULOSKELETAL STIFFNESS 271 0.0031
434 FAILURE TO THRIVE 16 0.0031
435 ORAL PAIN 69 0.0031
436 COELIAC DISEASE 30 0.0031
437 SPINAL FRACTURE 61 0.0030
438 LYMPHOPENIA 43 0.0030
439 HELICOBACTER INFECTION 31 0.0030
440 BASAL CELL CARCINOMA 47 0.0030
441 CYTOLYTIC HEPATITIS 10 0.0030
442 HYPERNATRAEMIA 15 0.0030
443 OEDEMA 161 0.0030
444 SKIN FISSURES 58 0.0030
445 HEPATOCELLULAR INJURY 42 0.0030
446 PHARYNGITIS STREPTOCOCCAL 32 0.0030
447 GRIP STRENGTH DECREASED 26 0.0030
448 GESTATIONAL DIABETES 14 0.0029
449 BREAST CANCER STAGE III 19 0.0029
450 PROTEIN TOTAL DECREASED 11 0.0029
451 ARTHRALGIA 1207 0.0029
452 MYOSITIS 26 0.0029
453 MUSCLE INJURY 24 0.0029
454 MYOCARDITIS 33 0.0029
455 AUTOIMMUNE HEPATITIS 20 0.0029
456 EOSINOPHILIA 50 0.0029
457 INJECTION SITE DISCOMFORT 30 0.0028
458 URTICARIA 477 0.0028
459 EAR INFECTION 75 0.0028
460 UROSEPSIS 26 0.0028
461 ANKYLOSING SPONDYLITIS 37 0.0028
462 GAIT INABILITY 93 0.0028
463 INTESTINAL PERFORATION 31 0.0028
464 JOINT RANGE OF MOTION DECREASED 37 0.0028
465 LUPUS-LIKE SYNDROME 25 0.0028
466 SARCOIDOSIS 13 0.0027
467 INJECTION SITE NODULE 30 0.0027
468 WOUND 76 0.0027
469 PERIPHERAL SWELLING 418 0.0027
470 SPINAL FUSION SURGERY 11 0.0027
471 SKIN NECROSIS 14 0.0027
472 SKIN MASS 18 0.0027
473 ABSCESS 43 0.0027
474 INTRACRANIAL PRESSURE INCREASED 15 0.0027
475 BONE DENSITY ABNORMAL 10 0.0027
476 SKIN INFECTION 30 0.0027
477 STATUS EPILEPTICUS 30 0.0027
478 TOOTH DISORDER 59 0.0027
479 VASCULAR DEVICE INFECTION 12 0.0026
480 PULMONARY HYPERTENSION 55 0.0026
481 THERAPEUTIC RESPONSE DECREASED 160 0.0026
482 NYSTAGMUS 14 0.0026
483 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
484 PAIN 1603 0.0026
485 PRODUCT USE ISSUE 490 0.0026
486 BLOOD PRESSURE FLUCTUATION 62 0.0026
487 CYST 32 0.0026
488 VIRAL LOAD INCREASED 10 0.0026
489 PULMONARY TUBERCULOSIS 11 0.0026
490 UMBILICAL HERNIA 12 0.0026
491 DIARRHOEA HAEMORRHAGIC 24 0.0026
492 CARDIOPULMONARY FAILURE 10 0.0026
493 GOUT 46 0.0026
494 ORAL INFECTION 10 0.0026
495 SKIN REACTION 36 0.0026
496 HEPATIC ENZYME INCREASED 174 0.0025
497 RENAL TUBULAR NECROSIS 25 0.0025
498 LEUKOCYTOSIS 46 0.0025
499 INTENTIONAL DOSE OMISSION 72 0.0025
500 CONTUSION 243 0.0025
501 HYPERSENSITIVITY 465 0.0025
502 HYPERCHOLESTEROLAEMIA 24 0.0025
503 ENCEPHALOPATHY 60 0.0024
504 AGRANULOCYTOSIS 45 0.0024
505 PHARYNGITIS 30 0.0024
506 TRANSAMINASES INCREASED 53 0.0024
507 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
508 OSTEOPENIA 36 0.0024
509 JOINT DISLOCATION 25 0.0024
510 SUBARACHNOID HAEMORRHAGE 24 0.0024
511 SYRINGE ISSUE 41 0.0023
512 RESPIRATORY FAILURE 170 0.0023
513 JOINT STIFFNESS 61 0.0023
514 HEPATITIS B 14 0.0023
515 PROTEINURIA 44 0.0023
516 ESCHERICHIA INFECTION 19 0.0023
517 PSYCHIATRIC SYMPTOM 17 0.0023
518 FOETAL GROWTH RESTRICTION 14 0.0023
519 PNEUMONIA BACTERIAL 21 0.0023
520 UVEITIS 31 0.0023
521 RASH 996 0.0023
522 INFLAMMATORY BOWEL DISEASE 22 0.0022
523 PSORIATIC ARTHROPATHY 91 0.0022
524 OSTEOPOROSIS 92 0.0022
525 RASH MACULAR 78 0.0022
526 PRODUCT LABEL CONFUSION 13 0.0022
527 GRAFT VERSUS HOST DISEASE 16 0.0022
528 PANCYTOPENIA 124 0.0022
529 HAEMOLYSIS 17 0.0022
530 CATARACT 131 0.0022
531 FOLLICULITIS 23 0.0022
532 UPPER-AIRWAY COUGH SYNDROME 18 0.0022
533 ACUTE GRAFT VERSUS HOST DISEASE 10 0.0022
534 SPINAL COMPRESSION FRACTURE 18 0.0022
535 NAIL DISORDER 19 0.0022
536 BONE MARROW FAILURE 44 0.0022
537 COAGULOPATHY 36 0.0022
538 TUMOUR LYSIS SYNDROME 19 0.0022
539 SINUSITIS 220 0.0021
540 KIDNEY INFECTION 42 0.0021
541 HEART RATE DECREASED 75 0.0021
542 DRUG-INDUCED LIVER INJURY 67 0.0021
543 WALKING AID USER 14 0.0021
544 MATERNAL EXPOSURE DURING PREGNANCY 189 0.0021
545 ILLNESS 218 0.0021
546 NIGHT SWEATS 68 0.0021
547 PRODUCT USE IN UNAPPROVED INDICATION 523 0.0021
548 VITAMIN D DECREASED 18 0.0021
549 RASH PRURITIC 114 0.0021
550 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
551 PYELONEPHRITIS 18 0.0021
552 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
553 ORAL CANDIDIASIS 27 0.0020
554 ADVERSE DRUG REACTION 184 0.0020
555 LABORATORY TEST ABNORMAL 60 0.0020
556 COVID-19 PNEUMONIA 24 0.0020
557 NEEDLE ISSUE 59 0.0020
558 HIP ARTHROPLASTY 31 0.0020
559 HEPATIC ENZYME ABNORMAL 10 0.0020
560 INFUSION RELATED REACTION 132 0.0020
561 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
562 EXOSTOSIS 18 0.0020
563 RASH ERYTHEMATOUS 94 0.0020
564 ANGIOPATHY 11 0.0020
565 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
566 FUNGAL INFECTION 65 0.0019
567 INFLUENZA 217 0.0019
568 PRODUCT DISTRIBUTION ISSUE 18 0.0019
569 HYPERTENSION 411 0.0019
570 UPPER RESPIRATORY TRACT INFECTION 89 0.0019
571 EOSINOPHIL COUNT INCREASED 16 0.0019
572 RESPIRATORY TRACT INFECTION 50 0.0019
573 GASTROENTERITIS 28 0.0019
574 HERPES VIRUS INFECTION 11 0.0019
575 GASTROINTESTINAL INFECTION 17 0.0019
576 SKIN WARM 11 0.0019
577 VOMITING 884 0.0019
578 HYPERCALCAEMIA 23 0.0019
579 MASS 26 0.0019
580 PRODUCT DOSE OMISSION 121 0.0019
581 HYSTERECTOMY 16 0.0018
582 HEPATITIS ACUTE 12 0.0018
583 BACK INJURY 20 0.0018
584 STAPHYLOCOCCAL INFECTION 60 0.0018
585 SARS-COV-2 TEST POSITIVE 24 0.0018
586 UNDERDOSE 132 0.0018
587 DRUG RESISTANCE 46 0.0018
588 BRONCHIECTASIS 12 0.0018
589 FURUNCLE 14 0.0018
590 ASPARTATE AMINOTRANSFERASE INCREASED 93 0.0017
591 PHARYNGEAL SWELLING 17 0.0017
592 MOUTH SWELLING 10 0.0017
593 HEPATOMEGALY 17 0.0017
594 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
595 CONJUNCTIVITIS 32 0.0017
596 HYPOTENSION 346 0.0017
597 ACUTE RESPIRATORY FAILURE 33 0.0017
598 ALANINE AMINOTRANSFERASE INCREASED 105 0.0017
599 HYPOXIA 60 0.0017
600 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 11 0.0017
601 ANORECTAL DISCOMFORT 9 0.0017
602 SPINAL DISORDER 16 0.0017
603 ABDOMINAL DISCOMFORT 282 0.0017
604 EXPOSURE DURING PREGNANCY 104 0.0017
605 DERMATITIS 35 0.0017
606 TYPE 2 DIABETES MELLITUS 56 0.0017
607 NASOPHARYNGITIS 305 0.0017
608 MENINGITIS 11 0.0016
609 PNEUMOTHORAX 26 0.0016
610 ULCER HAEMORRHAGE 11 0.0016
611 EMOTIONAL DISORDER 50 0.0016
612 SPINAL PAIN 19 0.0016
613 DISABILITY 32 0.0016
614 TACHYPNOEA 22 0.0016
615 BACTERIAL INFECTION 30 0.0016
616 PREGNANCY 32 0.0016
617 EYE INFECTION 18 0.0016
618 RENAL IMPAIRMENT 133 0.0016
619 THROMBOCYTOPENIA 176 0.0016
620 MALAISE 690 0.0016
621 RESPIRATORY DISORDER 47 0.0016
622 BLOOD URIC ACID INCREASED 9 0.0016
623 HAEMOGLOBIN DECREASED 160 0.0016
624 FOOD ALLERGY 12 0.0016
625 ATELECTASIS 15 0.0016
626 DISEASE PROGRESSION 183 0.0015
627 EAR PAIN 30 0.0015
628 LIP DRY 14 0.0015
629 NEUROTOXICITY 27 0.0015
630 GASTROINTESTINAL DISORDER 138 0.0015
631 IRRITABLE BOWEL SYNDROME 33 0.0015
632 ANAPHYLACTIC REACTION 85 0.0015
633 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 45 0.0015
634 PULMONARY HAEMORRHAGE 12 0.0015
635 URINARY TRACT INFECTION 260 0.0015
636 SCRATCH 16 0.0015
637 INJECTION SITE HAEMATOMA 22 0.0015
638 ACUTE KIDNEY INJURY 230 0.0015
639 ANAEMIA 286 0.0015
640 BLOOD DISORDER 12 0.0015
641 OROPHARYNGEAL PAIN 138 0.0015
642 POSTOPERATIVE WOUND INFECTION 10 0.0015
643 WEIGHT INCREASED 331 0.0015
644 SKIN ULCER 38 0.0015
645 DRUG ERUPTION 26 0.0015
646 BLISTER 82 0.0015
647 POOR VENOUS ACCESS 15 0.0014
648 PREMATURE DELIVERY 23 0.0014
649 PETECHIAE 15 0.0014
650 ABDOMINAL PAIN 334 0.0014
651 WHITE BLOOD CELL COUNT INCREASED 55 0.0014
652 PNEUMONITIS 39 0.0014
653 SLEEP DISORDER 101 0.0014
654 BLOOD TEST ABNORMAL 20 0.0014
655 RESPIRATORY DISTRESS 39 0.0014
656 CHOLESTASIS 27 0.0014
657 PNEUMONIA 455 0.0014
658 DRUG EFFECT INCOMPLETE 51 0.0014
659 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
660 SKIN LESION 38 0.0014
661 PRODUCT PRESCRIBING ISSUE 30 0.0014
662 BODY TEMPERATURE INCREASED 28 0.0014
663 FRUSTRATION TOLERANCE DECREASED 11 0.0014
664 LYMPHOMA 21 0.0014
665 DIARRHOEA 874 0.0014
666 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
667 SHOCK 31 0.0013
668 FACIAL PAIN 12 0.0013
669 NEPHROPATHY TOXIC 15 0.0013
670 PRODUCT USE COMPLAINT 21 0.0013
671 SYNCOPE 132 0.0013
672 DRUG EFFECT DECREASED 71 0.0013
673 MEDICATION ERROR 73 0.0013
674 HAEMODIALYSIS 11 0.0013
675 OSTEONECROSIS 43 0.0013
676 HEPATIC FAILURE 39 0.0013
677 COLITIS 49 0.0013
678 SKIN DISCOLOURATION 59 0.0013
679 MIGRAINE 122 0.0013
680 HEPATIC CIRRHOSIS 24 0.0013
681 ABORTION INDUCED 12 0.0013
682 RASH GENERALISED 33 0.0013
683 GASTROINTESTINAL PAIN 14 0.0013
684 BURNING SENSATION 88 0.0013
685 LOWER RESPIRATORY TRACT INFECTION 57 0.0013
686 TRANSPLANT REJECTION 10 0.0012
687 DIABETES MELLITUS 95 0.0012
688 RESPIRATORY RATE INCREASED 11 0.0012
689 ALOPECIA 243 0.0012
690 POST PROCEDURAL INFECTION 10 0.0012
691 TACHYCARDIA 109 0.0012
692 BEDRIDDEN 16 0.0012
693 NAUSEA 961 0.0012
694 ERYTHEMA 248 0.0012
695 NEUTROPENIA 163 0.0012
696 ABDOMINAL PAIN UPPER 246 0.0012
697 GLAUCOMA 23 0.0012
698 FEAR 32 0.0012
699 BLOOD IRON DECREASED 14 0.0012
700 LIMB INJURY 32 0.0012
701 ANGIOEDEMA 52 0.0012
702 DEVICE RELATED INFECTION 18 0.0012
703 RASH MACULO-PAPULAR 26 0.0012
704 BLOOD PRESSURE INCREASED 178 0.0012
705 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
706 HIATUS HERNIA 15 0.0012
707 PLATELET COUNT INCREASED 15 0.0011
708 BLOOD ALBUMIN DECREASED 9 0.0011
709 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
710 MUSCULAR WEAKNESS 128 0.0011
711 PRURITUS 431 0.0011
712 ADVERSE EVENT 103 0.0011
713 BODY TEMPERATURE DECREASED 11 0.0011
714 RASH PAPULAR 25 0.0011
715 LIGAMENT SPRAIN 11 0.0011
716 EPILEPSY 34 0.0011
717 ANAL INCONTINENCE 10 0.0011
718 INSURANCE ISSUE 17 0.0011
719 PARAESTHESIA ORAL 16 0.0011
720 LIVER DISORDER 49 0.0011
721 MYOCARDIAL INFARCTION 192 0.0011
722 ACUTE HEPATIC FAILURE 15 0.0011
723 DISEASE RECURRENCE 52 0.0011
724 LOWER LIMB FRACTURE 21 0.0011
725 VENTRICULAR TACHYCARDIA 18 0.0011
726 NERVOUS SYSTEM DISORDER 34 0.0011
727 JAUNDICE 29 0.0011
728 HYPOMAGNESAEMIA 15 0.0011
729 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
730 NEUTROPHIL COUNT INCREASED 11 0.0011
731 INFLUENZA LIKE ILLNESS 88 0.0011
732 CHEST PAIN 198 0.0011
733 NEPHROLITHIASIS 49 0.0011
734 BRONCHITIS 79 0.0011
735 PREMATURE BABY 32 0.0011
736 MITRAL VALVE INCOMPETENCE 12 0.0011
737 PAIN IN JAW 30 0.0011
738 INSOMNIA 282 0.0011
739 PAIN IN EXTREMITY 310 0.0011
740 WEIGHT FLUCTUATION 11 0.0011
741 CARDIAC FAILURE 84 0.0010
742 RENAL PAIN 11 0.0010
743 BACK PAIN 241 0.0010
744 GENERAL PHYSICAL HEALTH DETERIORATION 120 0.0010
745 TASTE DISORDER 21 0.0010
746 DERMATITIS ALLERGIC 13 0.0010
747 DIZZINESS 514 0.0010
748 LUNG INFECTION 16 0.0010
749 PULMONARY OEDEMA 46 0.0010
750 FEELING ABNORMAL 245 0.0010
751 HYPERGLYCAEMIA 37 0.0010
752 BLOOD UREA INCREASED 17 0.0010
753 DELIRIUM 35 0.0010
754 NEUTROPHIL COUNT DECREASED 41 0.0010
755 DISCOMFORT 61 0.0010
756 GASTRIC ULCER 19 0.0010
757 FATIGUE 777 0.0010
758 DEPRESSION 227 0.0010
759 GASTRITIS 26 0.0010
760 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
761 TOOTH INFECTION 13 0.0010
762 TOOTH ABSCESS 10 0.0010
763 BLOOD CALCIUM DECREASED 11 0.0010
764 CARDIOGENIC SHOCK 14 0.0010
765 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
766 MYELODYSPLASTIC SYNDROME 14 0.0010
767 BLOOD PRESSURE ABNORMAL 19 0.0010
768 CHOLECYSTITIS 11 0.0009
769 FOETAL EXPOSURE DURING PREGNANCY 75 0.0009
770 SEASONAL ALLERGY 13 0.0009
771 EYE SWELLING 34 0.0009
772 CYSTITIS 29 0.0009
773 WHEEZING 54 0.0009
774 HYPOTHYROIDISM 29 0.0009
775 PHOTOPHOBIA 17 0.0009
776 ABORTION SPONTANEOUS 36 0.0009
777 OCULAR DISCOMFORT 10 0.0009
778 BLOOD CREATININE INCREASED 58 0.0009
779 SINUS CONGESTION 12 0.0009
780 GAIT DISTURBANCE 169 0.0009
781 PRURITUS GENERALISED 19 0.0009
782 PRODUCT AVAILABILITY ISSUE 20 0.0009
783 SCAR 15 0.0009
784 HEADACHE 548 0.0009
785 TOXICITY TO VARIOUS AGENTS 146 0.0009
786 SWELLING FACE 56 0.0009
787 LOCAL SWELLING 15 0.0009
788 HAEMATOCRIT DECREASED 17 0.0009
789 CRYING 31 0.0009
790 MUSCULOSKELETAL CHEST PAIN 13 0.0008
791 ACCIDENT 10 0.0008
792 VERTIGO 51 0.0008
793 MYELOSUPPRESSION 30 0.0008
794 UNEVALUABLE EVENT 63 0.0008
795 BRAIN FOG 13 0.0008
796 HYPERTHYROIDISM 12 0.0008
797 NO THERAPEUTIC RESPONSE 10 0.0008
798 RHINORRHOEA 53 0.0008
799 CHILLS 96 0.0008
800 ASCITES 24 0.0008
801 RENAL DISORDER 38 0.0008
802 HYPOACUSIS 35 0.0008
803 MULTI-ORGAN FAILURE 14 0.0008
804 HEPATIC FUNCTION ABNORMAL 30 0.0008
805 MYALGIA 135 0.0008
806 BRAIN OEDEMA 10 0.0008
807 CARPAL TUNNEL SYNDROME 11 0.0008
808 PHARYNGEAL OEDEMA 12 0.0008
809 RIB FRACTURE 16 0.0008
810 LACTIC ACIDOSIS 25 0.0008
811 DIPLOPIA 20 0.0008
812 FLUSHING 78 0.0008
813 PNEUMONIA ASPIRATION 19 0.0008
814 MUSCULOSKELETAL DISCOMFORT 13 0.0008
815 SEIZURE 86 0.0007
816 DRY EYE 37 0.0007
817 FOOT FRACTURE 14 0.0007
818 PANCREATITIS 39 0.0007
819 INJURY ASSOCIATED WITH DEVICE 15 0.0007
820 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
821 COUGH 205 0.0007
822 POST PROCEDURAL COMPLICATION 14 0.0007
823 BONE PAIN 42 0.0007
824 PRODUCTIVE COUGH 34 0.0007
825 TENDONITIS 11 0.0007
826 FEBRILE NEUTROPENIA 47 0.0007
827 ECZEMA 37 0.0007
828 DYSPEPSIA 69 0.0007
829 INJECTION SITE HAEMORRHAGE 56 0.0007
830 HEAD INJURY 22 0.0007
831 DYSPNOEA 391 0.0007
832 ABDOMINAL DISTENSION 72 0.0007
833 INJURY 48 0.0007
834 LYMPHOCYTE COUNT DECREASED 12 0.0007
835 CARDIAC ARREST 56 0.0007
836 FEELING HOT 41 0.0007
837 ASTHENIA 251 0.0007
838 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
839 HYPERSOMNIA 19 0.0007
840 LIP SWELLING 22 0.0007
841 ATRIAL FIBRILLATION 64 0.0007
842 SUICIDAL IDEATION 60 0.0007
843 MEMORY IMPAIRMENT 90 0.0007
844 DYSSTASIA 19 0.0007
845 SKIN CANCER 14 0.0006
846 ROAD TRAFFIC ACCIDENT 27 0.0006
847 PRODUCT ADMINISTRATION ERROR 13 0.0006
848 FEEDING DISORDER 13 0.0006
849 OXYGEN SATURATION DECREASED 36 0.0006
850 HEART RATE INCREASED 63 0.0006
851 BLOOD POTASSIUM DECREASED 19 0.0006
852 OEDEMA PERIPHERAL 77 0.0006
853 NASAL CONGESTION 37 0.0006
854 RED BLOOD CELL COUNT DECREASED 18 0.0006
855 RESPIRATORY TRACT CONGESTION 10 0.0006
856 PLATELET COUNT DECREASED 67 0.0006
857 METABOLIC ACIDOSIS 20 0.0006
858 MUSCLE TIGHTNESS 10 0.0006
859 GASTRIC DISORDER 21 0.0006
860 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
861 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
862 BONE DISORDER 11 0.0006
863 UPPER LIMB FRACTURE 12 0.0006
864 MOVEMENT DISORDER 19 0.0006
865 BLOOD PRESSURE DECREASED 39 0.0006
866 TREATMENT NONCOMPLIANCE 32 0.0006
867 SNEEZING 13 0.0006
868 HEART RATE IRREGULAR 13 0.0006
869 NEOPLASM PROGRESSION 20 0.0006
870 CARDIO-RESPIRATORY ARREST 24 0.0006
871 DEAFNESS 15 0.0006
872 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
873 COLD SWEAT 10 0.0006
874 ABASIA 14 0.0006
875 WEIGHT DECREASED 157 0.0006
876 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
877 HYPOAESTHESIA 84 0.0006
878 BLOOD BILIRUBIN INCREASED 15 0.0006
879 PALLOR 15 0.0006
880 PRODUCT PRESCRIBING ERROR 13 0.0005
881 HAEMATOMA 14 0.0005
882 DEHYDRATION 72 0.0005
883 MENTAL IMPAIRMENT 13 0.0005
884 FLUID RETENTION 27 0.0005
885 DECREASED APPETITE 120 0.0005
886 CARDIAC DISORDER 48 0.0005
887 SWOLLEN TONGUE 16 0.0005
888 EPISTAXIS 38 0.0005
889 HAEMATOCHEZIA 28 0.0005
890 OCULAR HYPERAEMIA 24 0.0005
891 DRUG INTERACTION 78 0.0005
892 COMA 23 0.0005
893 FREQUENT BOWEL MOVEMENTS 13 0.0005
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
895 AMNESIA 31 0.0005
896 PARAESTHESIA 74 0.0005
897 VISUAL IMPAIRMENT 58 0.0005
898 ANAPHYLACTIC SHOCK 12 0.0005
899 FALL 152 0.0005
900 DEPRESSED MOOD 24 0.0005
901 NO ADVERSE EVENT 82 0.0005
902 CONFUSIONAL STATE 73 0.0005
903 IRRITABILITY 27 0.0004
904 ACNE 34 0.0004
905 EYE PRURITUS 15 0.0004
906 PRODUCT STORAGE ERROR 39 0.0004
907 PANCREATITIS ACUTE 10 0.0004
908 CHROMATURIA 10 0.0004
909 NERVOUSNESS 23 0.0004
910 HYPERHIDROSIS 56 0.0004
911 ASTHMA 49 0.0004
912 DRY MOUTH 35 0.0004
913 FEELING COLD 12 0.0004
914 APHASIA 13 0.0004
915 COGNITIVE DISORDER 20 0.0004
916 HAEMORRHAGE 44 0.0004
917 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
918 NEOPLASM MALIGNANT 28 0.0004
919 SKIN IRRITATION 19 0.0004
920 HAEMATURIA 14 0.0004
921 DYSURIA 15 0.0004
922 DRUG DEPENDENCE 65 0.0004
923 COLITIS ULCERATIVE 18 0.0004
924 DEATH 346 0.0004
925 RECTAL HAEMORRHAGE 17 0.0004
926 HAEMOPTYSIS 11 0.0004
927 CARDIOVASCULAR DISORDER 10 0.0004
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 69 0.0004
929 ANXIETY 108 0.0004
930 RENAL FAILURE ACUTE 16 0.0004
931 DYSPHONIA 22 0.0004
932 MOOD ALTERED 10 0.0004
933 CEREBRAL HAEMORRHAGE 13 0.0004
934 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
935 MUSCLE SPASMS 65 0.0004
936 ANGINA PECTORIS 10 0.0003
937 SOMNOLENCE 70 0.0003
938 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
939 CHEST DISCOMFORT 34 0.0003
940 SKIN EXFOLIATION 28 0.0003
941 VISUAL ACUITY REDUCED 11 0.0003
942 LETHARGY 19 0.0003
943 DISORIENTATION 13 0.0003
944 TINNITUS 15 0.0003
945 DERMATITIS ATOPIC 17 0.0003
946 BRADYCARDIA 17 0.0003
947 INTESTINAL OBSTRUCTION 12 0.0003
948 ARRHYTHMIA 15 0.0003
949 PRODUCT QUALITY ISSUE 43 0.0003
950 CHOLELITHIASIS 10 0.0003
951 EYE DISORDER 10 0.0003
952 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
953 MENTAL DISORDER 13 0.0003
954 HOSPITALISATION 45 0.0003
955 DYSARTHRIA 11 0.0003
956 LUNG NEOPLASM MALIGNANT 12 0.0003
957 SURGERY 17 0.0003
958 BALANCE DISORDER 25 0.0003
959 WITHDRAWAL SYNDROME 12 0.0003
960 THERAPY INTERRUPTED 20 0.0003
961 BREAST CANCER 26 0.0003
962 THROAT IRRITATION 12 0.0003
963 SPEECH DISORDER 14 0.0003
964 TREMOR 44 0.0003
965 PALPITATIONS 31 0.0003
966 DYSPHAGIA 25 0.0003
967 NEUROPATHY PERIPHERAL 25 0.0003
968 DRY SKIN 34 0.0003
969 CEREBROVASCULAR ACCIDENT 43 0.0003
970 CONSTIPATION 55 0.0003
971 HOT FLUSH 19 0.0003
972 ACCIDENTAL OVERDOSE 9 0.0002
973 VISION BLURRED 33 0.0002
974 EYE PAIN 13 0.0002
975 FLATULENCE 13 0.0002
976 BLOOD GLUCOSE INCREASED 40 0.0002
977 BLOOD GLUCOSE DECREASED 10 0.0002
978 EYE IRRITATION 11 0.0002
979 AGITATION 14 0.0002
980 INCORRECT DOSE ADMINISTERED 36 0.0002
981 HALLUCINATION 11 0.0001
982 EMOTIONAL DISTRESS 17 0.0001
983 SKIN BURNING SENSATION 10 0.0001
984 CARDIAC FAILURE CONGESTIVE 11 0.0001
985 DYSGEUSIA 10 0.0001
986 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
987 DRUG DOSE OMISSION 16 0.0001
988 OVERDOSE 20 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001